GILEAD SCIENCES INC 4
4 · GILEAD SCIENCES INC · Filed May 13, 2011
Insider Transaction Report
Form 4
BERG PAUL
Director
Transactions
- Exercise/Conversion
Common Stock
2011-05-11+3,820→ 35,820 total - Exercise/Conversion
Common Stock
2011-05-12+1,044→ 36,864 total - Exercise/Conversion
Restricted Stock Units
2011-05-11−3,820→ 0 total→ Common Stock (3,820 underlying) - Exercise/Conversion
Phantom Stock
2011-05-12−1,044→ 0 total→ Common Stock (1,044 underlying)
Footnotes (4)
- [F1]The shares of phantom stock were fully vested and, at the election of the reporting person, became payable in common stock upon the reporting person's termination of service as a director.
- [F2]Each share of phantom stock represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F3]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F4]100% of the restricted stock units vested on May 11, 2011, at the end of the first year of service.